Search

Michael P. Woodward

Examiner (ID: 16955)

Most Active Art Unit
1813
Art Unit(s)
1815, 1654, 1615, 1813, 1631, 1807, 1643, 1637
Total Applications
360
Issued Applications
165
Pending Applications
32
Abandoned Applications
163

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1165648 [patent_doc_number] => 06763087 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-13 [patent_title] => 'Mobile VDSL signal detector' [patent_app_type] => B2 [patent_app_number] => 10/095968 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3179 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/763/06763087.pdf [firstpage_image] =>[orig_patent_app_number] => 10095968 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/095968
Mobile VDSL signal detector Mar 12, 2002 Issued
09/959203 Composition for semi-permanent skin coloration Oct 21, 2001 Abandoned
09/962920 Molecules specific for NPFF Receptors and uses thereof Sep 23, 2001 Abandoned
Array ( [id] => 6838443 [patent_doc_number] => 20030035783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Cosmetic agent in the form of a gel' [patent_app_type] => new [patent_app_number] => 10/018933 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4028 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20030035783.pdf [firstpage_image] =>[orig_patent_app_number] => 10018933 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/018933
Cosmetic agent in the form of a gel Apr 6, 2001 Issued
Array ( [id] => 4420775 [patent_doc_number] => 06194601 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => '5,6-dihydronaphthalenyl derivatives having retinoid-like activity' [patent_app_type] => 1 [patent_app_number] => 9/397975 [patent_app_country] => US [patent_app_date] => 1999-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11443 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194601.pdf [firstpage_image] =>[orig_patent_app_number] => 397975 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/397975
5,6-dihydronaphthalenyl derivatives having retinoid-like activity Sep 15, 1999 Issued
Array ( [id] => 4131613 [patent_doc_number] => 06034056 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Fibronectin adhesion inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/860248 [patent_app_country] => US [patent_app_date] => 1997-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 16 [patent_no_of_words] => 30494 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034056.pdf [firstpage_image] =>[orig_patent_app_number] => 860248 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/860248
Fibronectin adhesion inhibitors Jun 23, 1997 Issued
Array ( [id] => 3756863 [patent_doc_number] => 05741495 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Glucan drug delivery system and adjuvant' [patent_app_type] => 1 [patent_app_number] => 8/810947 [patent_app_country] => US [patent_app_date] => 1997-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4179 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741495.pdf [firstpage_image] =>[orig_patent_app_number] => 810947 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/810947
Glucan drug delivery system and adjuvant Feb 26, 1997 Issued
Array ( [id] => 3837689 [patent_doc_number] => 05846934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Pure somatostatin antagonist and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/801374 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5524 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846934.pdf [firstpage_image] =>[orig_patent_app_number] => 801374 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/801374
Pure somatostatin antagonist and methods of use thereof Feb 18, 1997 Issued
Array ( [id] => 1283110 [patent_doc_number] => 06638552 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Glutenin genes and their uses' [patent_app_type] => B1 [patent_app_number] => 08/785716 [patent_app_country] => US [patent_app_date] => 1997-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7607 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638552.pdf [firstpage_image] =>[orig_patent_app_number] => 08785716 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/785716
Glutenin genes and their uses Jan 15, 1997 Issued
Array ( [id] => 3770547 [patent_doc_number] => 05807695 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Metallic cation binding polypeptides and methods therefor' [patent_app_type] => 1 [patent_app_number] => 8/773688 [patent_app_country] => US [patent_app_date] => 1996-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14302 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807695.pdf [firstpage_image] =>[orig_patent_app_number] => 773688 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/773688
Metallic cation binding polypeptides and methods therefor Dec 26, 1996 Issued
Array ( [id] => 3828924 [patent_doc_number] => 05814321 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Oil adjuvant vaccine and method for preparing same' [patent_app_type] => 1 [patent_app_number] => 8/758374 [patent_app_country] => US [patent_app_date] => 1996-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15933 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814321.pdf [firstpage_image] =>[orig_patent_app_number] => 758374 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/758374
Oil adjuvant vaccine and method for preparing same Nov 28, 1996 Issued
Array ( [id] => 3741192 [patent_doc_number] => 05800982 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Antigenic peptides for growing hepatitis C virus, kit comprising the same and methods for its grouping using the same' [patent_app_type] => 1 [patent_app_number] => 8/685764 [patent_app_country] => US [patent_app_date] => 1996-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14703 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/800/05800982.pdf [firstpage_image] =>[orig_patent_app_number] => 685764 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/685764
Antigenic peptides for growing hepatitis C virus, kit comprising the same and methods for its grouping using the same Jul 23, 1996 Issued
Array ( [id] => 4019972 [patent_doc_number] => 05907033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'Anti-oncostatin M monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/678922 [patent_app_country] => US [patent_app_date] => 1996-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 8219 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/907/05907033.pdf [firstpage_image] =>[orig_patent_app_number] => 678922 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/678922
Anti-oncostatin M monoclonal antibodies Jul 11, 1996 Issued
Array ( [id] => 3875055 [patent_doc_number] => 05824708 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Virucidal substances' [patent_app_type] => 1 [patent_app_number] => 8/649714 [patent_app_country] => US [patent_app_date] => 1996-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2600 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824708.pdf [firstpage_image] =>[orig_patent_app_number] => 649714 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/649714
Virucidal substances Jun 26, 1996 Issued
08/579088 MOUSE MONOCLONAL ANTIBODY (5-21-3) TO HUMAN IMMUNODEFICIENCY VIRUS GP41 PROTEIN Dec 26, 1995 Abandoned
Array ( [id] => 3789798 [patent_doc_number] => 05840855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Mycobacterial recombinants and peptides' [patent_app_type] => 1 [patent_app_number] => 8/577980 [patent_app_country] => US [patent_app_date] => 1995-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 24953 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840855.pdf [firstpage_image] =>[orig_patent_app_number] => 577980 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/577980
Mycobacterial recombinants and peptides Dec 21, 1995 Issued
Array ( [id] => 3655446 [patent_doc_number] => 05658746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Cell surface receptor complementation' [patent_app_type] => 1 [patent_app_number] => 8/552432 [patent_app_country] => US [patent_app_date] => 1995-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2634 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658746.pdf [firstpage_image] =>[orig_patent_app_number] => 552432 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/552432
Cell surface receptor complementation Nov 2, 1995 Issued
Array ( [id] => 4323809 [patent_doc_number] => RE037381 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Vaccine against hepatitis A virus' [patent_app_type] => 2 [patent_app_number] => 8/673408 [patent_app_country] => US [patent_app_date] => 1995-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4763 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037381.pdf [firstpage_image] =>[orig_patent_app_number] => 673408 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/673408
Vaccine against hepatitis A virus Sep 5, 1995 Issued
08/487840 METHOD OF MEDIATING INHIBITION OF FAS-LIGAND EXPRESSION THROUGH USE OF RETINOID COMPOUNDS Jun 6, 1995 Abandoned
Array ( [id] => 4398572 [patent_doc_number] => 06297355 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Polypeptides displaying HBV antigenicity or hbv antigen specificity' [patent_app_type] => 1 [patent_app_number] => 8/472301 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11365 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297355.pdf [firstpage_image] =>[orig_patent_app_number] => 472301 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/472301
Polypeptides displaying HBV antigenicity or hbv antigen specificity Jun 6, 1995 Issued
Menu